Breaking News

Russia studies using Mefloquine to treat COVID-19 for 48 hours

According to the Russian Federal Biomedical Agency (FMBA), the anti-malarial drug Mefloquine is able to completely inhibit the activity of SARS-CoV-2 virus within two days.

In the FMBA notice posted on its website, the pre-clinical study of the drug Mefloquine, conducted by FMBA and the Institute of Microbiology of the Ministry of Defense, showed very positive results.

Using Mefloquine in very small doses, only about 2 mg / ml, is capable of 100% inhibition of cytological efficacy of the virus after 48 hours, since its infection. 

However, if the drug is used before infection, the effectiveness of the drug is reduced to only 50 to 75%, so this drug has full potential to treat and prevent viruses.

No comments